Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?
Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Sponsor
Sponsor
For Practicing Oncologists
Cancer Science: T-cell/tumor-cell tethering antibody shows promise against refractory non-Hodgkin's lymphoma
Sara Hartley, MDLinx Oncology
Today's Oncology News: The HERS+ to HER2- Switch--Clinically Significant?
D Scott Cunningham MD, PhD, MDLinx Oncology
Noninvasive Biochemical Probe Uses Light to Detect Skin Cancers
Dorothy J. Schirf, MD, MDLinx Oncology
  See all
Concurrent chemoradiotherapy; p53; Phosphorylated p53 at the Ser392 residue; Docetaxel; Head and neck squamous cell carcinoma Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
p53 expression in concurrent chemoradiotherapy with docetaxel for head and neck squamous cell carcinoma
Auris Nasus Larynx, 06/27/08
Print     Email This Article     Save in My Library   Free Abstract
Oridate N et al. - An immunohistochemical assessment of the expression of p53 and its phosphorylated form might not be of clinical use in defining subgroups of patients with poor prognosis.
 

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

--- HEAD AND NECK TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

Sponsor
--- PHARMACOLOGY/THERAPY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email
Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
 Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
 Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
     Medical Students
Nurse Practitioner
Pharma/Drug Marketer
     Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.